{"id":457519,"date":"2021-03-15T08:33:13","date_gmt":"2021-03-15T12:33:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=457519"},"modified":"2021-03-15T08:33:13","modified_gmt":"2021-03-15T12:33:13","slug":"bionano-genomics-to-present-at-several-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/","title":{"rendered":"Bionano Genomics to Present at Several Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">SAN DIEGO, March  15, 2021  (GLOBE NEWSWIRE) &#8212; Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the following investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <a href=\"https:\/\/www.oppenheimer.com\/events\/2021\/31st-annual-healthcare-conference.aspx\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Oppenheimer 31<\/a><br \/>\n          <a href=\"https:\/\/www.oppenheimer.com\/events\/2021\/31st-annual-healthcare-conference.aspx\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n            <sup>st<\/sup><br \/>\n          <\/a><br \/>\n          <a href=\"https:\/\/www.oppenheimer.com\/events\/2021\/31st-annual-healthcare-conference.aspx\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"> Annual Healthcare Conference<\/a>, March 16-18, 2021<br \/>\u00a0 \u00a0 \u00a0 \u00ba\u00a0 Company management are scheduled to present on Wednesday, March 17, 2021 at 11:20 am ET.<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <a href=\"https:\/\/www.m-vest.com\/events\/2021-emerging-growth-virtual-conference\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Maxim Group\u2019s Emerging Growth Conference<\/a>, March 17-19, 2021.<br \/>\u00a0 \u00a0 \u00a0 \u00ba\u00a0 The presentation will be available to all registered participants of the conference on\u00a0March 17th &#8211; 19<sup>th<\/sup><\/li>\n<\/ul>\n<p>Webcasts will be available following each event on the Events page in the Investors section of Bionano\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zhB774CMNsis3PGb2BkHXsK5FOq6PHL8OY3BoCHMJUgaN6cowtDj2MLi-zR4N_bZ-c4Vp0Y9i4EDlUjxFZnKlp8mSje_wbCUPc_Ur2VChOJjcJdmpSn5LPxL7ZDXznOi\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/ir.bionanogenomics.com\/<\/a> and will be archived on Bionano\u2019s website for 30 days following the event.<\/p>\n<p>\n        <strong>About Bionano Genomics<\/strong><br \/>\n        <br \/>Bionano is a genome analysis company providing tools and services based on its Saphyr system to scientists and clinicians conducting genetic research and patient testing, and providing diagnostic testing for those with autism spectrum disorder (ASD) and other neurodevelopmental disabilities through its Lineagen business. Bionano\u2019s Saphyr system is a research use only platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. The Saphyr system is comprised of an instrument, chip consumables, reagents and a suite of data analysis tools. Bionano provides genome analysis services to provide access to data generated by the Saphyr system for researchers who prefer not to adopt the Saphyr system in their labs. Lineagen has been providing genetic testing services to families and their healthcare providers for over nine years and has performed over 65,000 tests for those with neurodevelopmental concerns. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=s419sa5MYSJtX6EcvsxbeZVJNLyc_vLA8eiI4qaR8eP4w4DpHFGJWnCDrJsy_gk5ko34LCKlpkld4MxvokPhq4gfaryV_ZlKd85zoEoBbFE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>www.bionanogenomics.com<\/u><\/a> or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-tWfLY0-fLlDPgz0EJLgf4PKwqDsHzj2c6KF_v7UU93VxoJxRAoSC55fnFzbypx1aLq58B2N9D_dkBk572-pOg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.lineagen.com<\/a>.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>Company Contact:<\/strong><br \/>\n        <br \/>Erik Holmlin, CEO<br \/>Bionano Genomics, Inc.<br \/>+1 (858) 888-7610<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=p97BVwRwVcM_3Gcmqeu2v3tYUoc32rWnrgGNV7rr-K_LhJrbnhEviKbVWnY5ttNRyzl62zrK1eqg5Xuv-uXVKymEvAPrOll7F1cPEP2D1NAmu4_ygZHr4XJ5gjrzsBX8\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>eholmlin@bionanogenomics.com<\/u><\/a><\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Ashley R. Robinson<br \/>LifeSci Advisors, LLC<br \/>+1 (617) 430-7577<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fEUHkZm39H2mtM_fe3FGIne_RDxtyTYcp_DQDk8CFy_g-i0Rtm4Q_ID9pbSp9HI1BS3zjxIQEOKaNZbHtN_JcJOxp-iBzh-71helKQX_UKo=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>arr@lifesciadvisors.com<\/u><\/a><\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Darren Opland, PhD<br \/>LifeSci Communications<br \/>+1 (617) 733-7668<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Lg5TNJgUnABabYXcakQsXVxL2-uzLfWOHc6NIT_lHzRWi3bL5pxtf2XpZ3InBAXOXpIIaIcLCIAiNuJHrcCqNsOqC6xOWBkn-uWeT8LDFTU=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><u>darren@lifescicomms.com<\/u><\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/414bc48c-aedb-41cd-97b5-6b17404aa2bd\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) &#8212; Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the following investor conferences: Oppenheimer 31 st Annual Healthcare Conference, March 16-18, 2021\u00a0 \u00a0 \u00a0 \u00ba\u00a0 Company management are scheduled to present on Wednesday, March 17, 2021 at 11:20 am ET. Maxim Group\u2019s Emerging Growth Conference, March 17-19, 2021.\u00a0 \u00a0 \u00a0 \u00ba\u00a0 The presentation will be available to all registered participants of the conference on\u00a0March 17th &#8211; 19th Webcasts will be available following each event on the Events page in the Investors section of Bionano\u2019s website at https:\/\/ir.bionanogenomics.com\/ and will be archived on Bionano\u2019s website for 30 days following the event. About Bionano Genomics Bionano is a genome &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bionano Genomics to Present at Several Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-457519","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bionano Genomics to Present at Several Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bionano Genomics to Present at Several Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) &#8212; Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the following investor conferences: Oppenheimer 31 st Annual Healthcare Conference, March 16-18, 2021\u00a0 \u00a0 \u00a0 \u00ba\u00a0 Company management are scheduled to present on Wednesday, March 17, 2021 at 11:20 am ET. Maxim Group\u2019s Emerging Growth Conference, March 17-19, 2021.\u00a0 \u00a0 \u00a0 \u00ba\u00a0 The presentation will be available to all registered participants of the conference on\u00a0March 17th &#8211; 19th Webcasts will be available following each event on the Events page in the Investors section of Bionano\u2019s website at https:\/\/ir.bionanogenomics.com\/ and will be archived on Bionano\u2019s website for 30 days following the event. About Bionano Genomics Bionano is a genome &hellip; Continue reading &quot;Bionano Genomics to Present at Several Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-15T12:33:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bionano Genomics to Present at Several Upcoming Investor Conferences\",\"datePublished\":\"2021-03-15T12:33:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/\"},\"wordCount\":325,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/\",\"name\":\"Bionano Genomics to Present at Several Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==\",\"datePublished\":\"2021-03-15T12:33:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bionano Genomics to Present at Several Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bionano Genomics to Present at Several Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Bionano Genomics to Present at Several Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) &#8212; Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the following investor conferences: Oppenheimer 31 st Annual Healthcare Conference, March 16-18, 2021\u00a0 \u00a0 \u00a0 \u00ba\u00a0 Company management are scheduled to present on Wednesday, March 17, 2021 at 11:20 am ET. Maxim Group\u2019s Emerging Growth Conference, March 17-19, 2021.\u00a0 \u00a0 \u00a0 \u00ba\u00a0 The presentation will be available to all registered participants of the conference on\u00a0March 17th &#8211; 19th Webcasts will be available following each event on the Events page in the Investors section of Bionano\u2019s website at https:\/\/ir.bionanogenomics.com\/ and will be archived on Bionano\u2019s website for 30 days following the event. About Bionano Genomics Bionano is a genome &hellip; Continue reading \"Bionano Genomics to Present at Several Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-15T12:33:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bionano Genomics to Present at Several Upcoming Investor Conferences","datePublished":"2021-03-15T12:33:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/"},"wordCount":325,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/","name":"Bionano Genomics to Present at Several Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==","datePublished":"2021-03-15T12:33:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4OTg5MiM0MDYzNzY2IzUwMDA1MjUyMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bionano-genomics-to-present-at-several-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bionano Genomics to Present at Several Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/457519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=457519"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/457519\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=457519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=457519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=457519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}